# Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis

> **NCT03310294** · NA · COMPLETED · sponsor: **Sprim Advanced Life Sciences** · enrollment: 157 (actual)

## Conditions studied

- Herpes Labialis

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Prebiotics and Probiotics

## Key facts

- **NCT ID:** NCT03310294
- **Lead sponsor:** Sprim Advanced Life Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-14
- **Primary completion:** 2011-05-05
- **Final completion:** 2011-08-01
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2017-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03310294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03310294, "Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03310294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
